These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. Cole LA, Butler S. J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011 [Abstract] [Full Text] [Related]
11. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay. Norman RJ, Buck RH, Joubert SM. S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933 [Abstract] [Full Text] [Related]
14. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease]. Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J. Rev Fr Gynecol Obstet; 1985 Oct 01; 80(10):737-52. PubMed ID: 2417299 [Abstract] [Full Text] [Related]
19. Measurement of CA-125 in trophoblastic disease. Kohorn EI. Gynecol Oncol; 2000 Jul 01; 78(1):39-42. PubMed ID: 10873407 [Abstract] [Full Text] [Related]
20. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin. Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G. Oncodev Biol Med; 1982 Jul 01; 3(4):315-23. PubMed ID: 6291007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]